Healthtech / Clinical Decision Support · 51–200 employees
Alcidion
Clinical decision support software for NHS trusts
What they do
Alcidion develops clinical decision support and patient flow software for hospitals and health systems. Their core product, Miya Precision, is deployed in NHS trusts across England, where it aggregates patient data from disparate hospital systems and presents it to clinicians in a usable form at the point of care.
The problem they are solving is a familiar one in NHS settings: patient information exists in multiple systems that do not talk to each other well. Clinicians waste time hunting for results, discharge summaries, observations and medication records across different screens. Miya Precision pulls that data together, adds configurable alerting and decision support rules, and presents a unified patient view. The aim is to reduce the time between a clinical event and an appropriate response.
Patient flow is the other main area. Hospitals need to know where patients are, how long they have been there, and where they are going next. Alcidion's software supports bed management and discharge planning, which matters particularly in a health system under sustained pressure on capacity.
What sets them apart
Alcidion's focus is specifically on the clinical intelligence layer rather than on replacing the underlying electronic patient record. That is a deliberate positioning choice. Many NHS trusts already have EPR systems from large vendors and are not in a position to replace them. Alcidion sits on top of those systems, reading data through integrations and adding the decision support and alerting capability that the core EPR often lacks or delivers poorly.
This approach means Alcidion can be deployed without requiring a trust to undertake a full EPR replacement programme, which is a significant procurement and implementation undertaking. It also means the product has to be good at integration — connecting to a wide variety of source systems across different trust configurations.
The company is listed on the Australian Securities Exchange (ASX), with origins in Australia and New Zealand, and has expanded into the UK NHS market. That international background means they have experience deploying in different health system contexts, though the NHS has its own particular integration standards, procurement routes and clinical workflows.
For Leeds and the wider Yorkshire NHS market, Alcidion represents the kind of healthtech supplier that operates at the intersection of clinical informatics and software engineering — a space that requires both domain knowledge and technical delivery capability. The NHS Long Term Plan's push toward digitisation has created sustained demand for exactly this kind of product, and Alcidion has positioned itself to serve that demand in the English market.
What they offer
- Miya Precision — clinical decision support platform that aggregates patient data across hospital systems and delivers real-time alerts and decision support to clinicians at the point of care.
- Patient flow software — bed management and discharge planning tools designed to help hospitals manage capacity and patient movement across wards.
FAQs
- What does Alcidion do?
- Alcidion builds clinical decision support and patient flow software for hospitals. Their main product, Miya Precision, is deployed in NHS trusts in England, where it aggregates patient data from multiple hospital systems and provides real-time alerting and decision support to clinicians.
- What is Miya Precision?
- Miya Precision is Alcidion's flagship software platform. It connects to existing hospital systems, pulls together patient data, and presents it to clinical staff alongside configurable alerts and decision support rules. It is designed to sit on top of existing electronic patient records rather than replace them.
- Which NHS trusts use Alcidion software?
- Alcidion's software is deployed in NHS trusts across England. Specific trust names are not confirmed in the available source material, but the company has publicly referenced NHS deployments as a core part of its UK market activity.
- Where is Alcidion based?
- Alcidion is listed on the Australian Securities Exchange and has origins in Australia and New Zealand. The company has a UK presence serving the NHS market, though a specific UK office location is not confirmed in the available source material.
- Does Alcidion replace a hospital's EPR system?
- No. Alcidion's approach is to integrate with existing electronic patient record systems rather than replace them. Miya Precision reads data from source systems through integrations and adds a clinical decision support and alerting layer on top.
- What sector does Alcidion operate in?
- Alcidion operates in healthtech, specifically in clinical decision support and patient flow management for hospital settings. Their primary UK market is the NHS.